“This white paper reviews different approaches to electronic surveillance, discusses the specific data elements required for performing surveillance, and considers important issues of data validation.” Woeltje et al (2014).
Reference:
Woeltje, K.F., Lin, M.Y., Klompas, M., Wright, M.O., Zuccotti, G. and Trick, W.E. (2014) SHEA White Paper: Data Requirements for Electronic Surveillance of Healthcare-Associated Infections. Infection Control and Hospital Epidemiology. 35(9), p.1083-1091.
[ctt tweet=” SHEA White Paper: Data requirements for electronic surveillance http://ctt.ec/3AWDp+ @ivteam #ivteam” coverup=”3AWDp”]
Abstract:
Electronic surveillance for healthcare-associated infections (HAIs) is increasingly widespread. This is driven by multiple factors: a greater burden on hospitals to provide surveillance data to state and national agencies, financial pressures to be more efficient with HAI surveillance, the desire for more objective comparisons between healthcare facilities, and the increasing amount of patient data available electronically. Optimal implementation of electronic surveillance requires that specific information be available to the surveillance systems. This white paper reviews different approaches to electronic surveillance, discusses the specific data elements required for performing surveillance, and considers important issues of data validation.
View full text.
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.
